Public COA audit

Triple Agonist · Retatrutide

Audited July 28, 2026

Mostly consistent, with concerns

Several fields check out, but we found issues worth reviewing before you rely on this document.

Legitimacy
92
Confidence
88%
Panels
5/7
Purity (printed)
99.92%

Document details

Fields extracted from the certificate — not order or payment data.

Batch / lot
CR-3XAG-10-2607-YELLOW
Identity method
HPLC-RTM (retention time comparison with reference standard)
Sample date
2026-07-06
Issue date
2026-07-21

7-panel checklist

Had data + good, had data + bad, reported without pass/fail, or missing. Missing lowers thoroughness — you decide whether that panel matters; PeptIQ’s score still factors coverage.

5 of 7 present · 5 passed · 0 failed · 0 reported · 2 missing

Missing is a thoroughness gap — not automatically bad. PeptIQ’s legitimacy score still weighs panel coverage; you can down-weight panels that don’t matter for your use case.

  • Identity

    Tested · passed · core

    Compound identity confirmed (e.g. HPLC, mass spec).

    Confirmed (Retatrutide)

  • Purity

    Tested · passed · core

    Reported purity percentage for the analyte.

    99.92%

  • Heavy metals

    Tested · passed

    Lead, arsenic, cadmium, mercury, or similar limits.

    As: 0.454 ppm, Cd/Pb/Hg/Cr: Not Detected

  • Microbial

    Not on this COA

    Bioburden / microbial limits testing.

    No evidence for this panel. That lowers thoroughness — whether it matters depends on what you care about.

  • Endotoxin

    Tested · passed · core

    LAL or chromogenic endotoxin assay.

    0.854 EU/mL

  • Sterility

    Tested · passed

    Sterility testing where applicable.

    No Growth

  • Residual solvent / water

    Not on this COA

    Residual solvents or water content limits.

    No evidence for this panel. That lowers thoroughness — whether it matters depends on what you care about.

How to read this

Had data · good

Panel present with a pass (or clear acceptance).

Had data · bad

Panel present with a fail — a concrete quality signal.

Had data · unclear

Value reported without an explicit pass/fail mark.

Missing

Not on this certificate. Lowers thoroughness; you decide if that panel matters for your use case. PeptIQ’s score still factors coverage.

Findings

Evidence-linked observations from this audit.

  • High purity confirmed

    99.92% purity by HPLC with conformity testing across 3 samples (mean 99.88%, std dev 0.0327%) demonstrates excellent batch consistency

  • Identity confirmed

    Retatrutide confirmed by HPLC retention time comparison with reference standard, includes fentanyl screen (not detected)

  • Batch information complete

    Lot CR-3XAG-10-2607-YELLOW, COA-2026-Q961ZW, Accession ACC-2026-8203

  • Dates consistent

    Received 2026-07-06, analyzed and issued 2026-07-21 (15-day turnaround is reasonable)

  • Lab credentials present

    ILS Laboratories, San Diego CA, ISO/IEC 17025 accredited, includes verification URL and access code

  • Comprehensive testing panel

    Includes purity, identity, heavy metals, endotoxin, and sterility testing. Missing microbial count and residual solvent panels, but this is common for research peptides

  • Professional presentation

    Well-formatted with chromatogram, conformity testing data, methodology notes, and proper accreditation statements

  • Lab verification recommended

    While the COA appears legitimate, independent verification via the provided URL (portal.ils-lab.com/verify/v3-p2h_E8JgedfgN) with access code 3HHTNRGC is recommended to confirm authenticity

PeptIQ COA reports analyze document content and publicly verifiable lab signals. They are educational and not a guarantee of product quality, legality, or safety. Always consult a qualified professional before making health decisions. We never publish purchase prices, shipping details, or uploader identity.